258 related articles for article (PubMed ID: 24751794)
1. Soluble ST2 and interleukin-33 levels in coronary artery disease: relation to disease activity and adverse outcome.
Demyanets S; Speidl WS; Tentzeris I; Jarai R; Katsaros KM; Farhan S; Krychtiuk KA; Wonnerth A; Weiss TW; Huber K; Wojta J
PLoS One; 2014; 9(4):e95055. PubMed ID: 24751794
[TBL] [Abstract][Full Text] [Related]
2. Increased soluble ST2 predicts long-term mortality in patients with stable coronary artery disease: results from the Ludwigshafen risk and cardiovascular health study.
Dieplinger B; Egger M; Haltmayer M; Kleber ME; Scharnagl H; Silbernagel G; de Boer RA; Maerz W; Mueller T
Clin Chem; 2014 Mar; 60(3):530-40. PubMed ID: 24401186
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-33/sST2: Dynamic assessment in patients with acute coronary syndrome.
Witkowska A; Staciwa M; Duraj I; Wozniak E; Broncel M; Gorzelak-Pabis P
Adv Med Sci; 2023 Sep; 68(2):195-201. PubMed ID: 37216709
[TBL] [Abstract][Full Text] [Related]
4. Predicting value of serum soluble ST2 and interleukin-33 for risk stratification and prognosis in patients with acute myocardial infarction.
Zhang K; Zhang XC; Mi YH; Liu J
Chin Med J (Engl); 2013; 126(19):3628-31. PubMed ID: 24112154
[TBL] [Abstract][Full Text] [Related]
5. Increased Plasma Concentrations of Soluble ST2 Independently Predict Mortality but not Cardiovascular Events in Stable Coronary Heart Disease Patients: 13-Year Follow-up of the KAROLA Study.
Pfetsch V; Sanin V; Jaensch A; Dallmeier D; Mons U; Brenner H; Koenig W; Rothenbacher D
Cardiovasc Drugs Ther; 2017 Apr; 31(2):167-177. PubMed ID: 28283847
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 33 and ST2 in non-ST-elevation myocardial infarction: comparison with Global Registry of Acute Coronary Events Risk Scoring and NT-proBNP.
Dhillon OS; Narayan HK; Quinn PA; Squire IB; Davies JE; Ng LL
Am Heart J; 2011 Jun; 161(6):1163-70. PubMed ID: 21641364
[TBL] [Abstract][Full Text] [Related]
7. [Clinical implication and association between local and systemic levels of interleukin-1β and interleukin-10 in patients with coronary artery disease].
Yan HB; Li WZ; Zhao HJ; Song L; Zheng B; Zhou P; Liu C
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Feb; 39(2):142-6. PubMed ID: 21426749
[TBL] [Abstract][Full Text] [Related]
8. An increase of interleukin-33 serum levels after coronary stent implantation is associated with coronary in-stent restenosis.
Demyanets S; Tentzeris I; Jarai R; Katsaros KM; Farhan S; Wonnerth A; Weiss TW; Wojta J; Speidl WS; Huber K
Cytokine; 2014 Jun; 67(2):65-70. PubMed ID: 24725541
[TBL] [Abstract][Full Text] [Related]
9. Association of galectin-3 and soluble ST2 with in-hospital and 1-year outcomes in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Tymińska A; Kapłon-Cieślicka A; Ozierański K; Budnik M; Wancerz A; Sypień P; Peller M; Maksym J; Balsam P; Opolski G; Filipiak KJ
Pol Arch Intern Med; 2019 Nov; 129(11):770-780. PubMed ID: 31642446
[TBL] [Abstract][Full Text] [Related]
10. Soluble ST2 in Patients with Carotid Artery Stenosis-Association with Plaque Morphology and Long-Term Outcome.
Stojkovic S; Kampf S; Harkot O; Nackenhorst M; Brekalo M; Huber K; Hengstenberg C; Neumayer C; Wojta J; Demyanets S
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240352
[TBL] [Abstract][Full Text] [Related]
11. Serum level of interleukin-33 and soluble ST2 and their association with disease activity in patients with Behcet's disease.
Kim DJ; Baek SY; Park MK; Park KS; Lee JH; Park SH; Kim HY; Kwok SK
J Korean Med Sci; 2013 Aug; 28(8):1145-53. PubMed ID: 23960440
[TBL] [Abstract][Full Text] [Related]
12. Comparison Between Soluble ST2 and High-Sensitivity Troponin I in Predicting Short-Term Mortality for Patients Presenting to the Emergency Department With Chest Pain.
Marino R; Magrini L; Orsini F; Russo V; Cardelli P; Salerno G; Hur M; Di Somma S;
Ann Lab Med; 2017 Mar; 37(2):137-146. PubMed ID: 28029000
[TBL] [Abstract][Full Text] [Related]
13. Serum soluble ST2 is associated with ER-positive breast cancer.
Lu DP; Zhou XY; Yao LT; Liu CG; Ma W; Jin F; Wu YF
BMC Cancer; 2014 Mar; 14():198. PubMed ID: 24636276
[TBL] [Abstract][Full Text] [Related]
14. Multibiomarker analysis in patients with acute myocardial infarction.
Schernthaner C; Lichtenauer M; Wernly B; Paar V; Pistulli R; Rohm I; Jung C; Figulla HR; Yilmaz A; Cadamuro J; Haschke-Becher E; Pernow J; Schulze PC; Hoppe UC; Kretzschmar D
Eur J Clin Invest; 2017 Sep; 47(9):638-648. PubMed ID: 28683166
[TBL] [Abstract][Full Text] [Related]
15. Long-term clinical outcomes in patients with unstable angina undergoing percutaneous coronary interventions in a contemporary registry data from Poland.
Piątek Ł; Janion-Sadowska A; Piątek K; Zandecki Ł; Zabojszcz M; Siudak Z; Sadowski M
Coron Artery Dis; 2020 May; 31(3):215-221. PubMed ID: 31821194
[TBL] [Abstract][Full Text] [Related]
16. IL1RL1 single nucleotide polymorphism predicts sST2 level and mortality in coronary and peripheral artery disease.
Lin JF; Wu S; Juang JJ; Chiang FT; Hsu LA; Teng MS; Cheng ST; Huang HL; Sun YC; Liu PY; Ko YL
Atherosclerosis; 2017 Feb; 257():71-77. PubMed ID: 28110258
[TBL] [Abstract][Full Text] [Related]
17. Improved early risk stratification of patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention using a combination of serum soluble ST2 and NT-proBNP.
Yu J; Oh PC; Kim M; Moon J; Park YM; Lee K; Suh SY; Han SH; Byun K; Ahn T; Kang WC
PLoS One; 2017; 12(8):e0182829. PubMed ID: 28796845
[TBL] [Abstract][Full Text] [Related]
18. High plasma levels of soluble ST2 but not its ligand IL-33 is associated with severe forms of pediatric dengue.
Guerrero CD; Arrieta AF; Ramirez ND; Rodríguez LS; Vega R; Bosch I; Rodríguez JA; Narváez CF; Salgado DM
Cytokine; 2013 Mar; 61(3):766-71. PubMed ID: 23357301
[TBL] [Abstract][Full Text] [Related]
19. Prognostic role of soluble ST2 in acute coronary syndrome with diabetes.
Jha D; Goenka L; Ramamoorthy T; Sharma M; Dhandapani VE; George M
Eur J Clin Invest; 2018 Sep; 48(9):e12994. PubMed ID: 29992539
[TBL] [Abstract][Full Text] [Related]
20. The levels of soluble ST2 in sera and bullous fluid from patients with bullous pemphigoid.
Wakatabi K; Komine M; Meephansan J; Matsuyama Y; Tsuda H; Tominaga S; Ohtsuki M
Eur J Dermatol; 2012; 22(3):333-6. PubMed ID: 22494834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
